Opioid-Induced Constipation Among Patients with Chronic Noncancer Pain in the United States, Canada, Germany, and the United Kingdom: Laxative Use, Response, and Symptom Burden Over Time
Open Access
- 1 August 2015
- journal article
- Published by Oxford University Press (OUP) in Pain Medicine
- Vol. 16 (8), 1551-1565
- https://doi.org/10.1111/pme.12724
Abstract
Purpose. Estimate rate of laxative inadequate response (LIR) over time among patients with chronic noncancer pain with opioid-induced constipation (OIC)Keywords
Funding Information
- AstraZeneca (NA)
This publication has 20 references indexed in Scilit:
- The impact of laxative use upon symptoms in patients with proven slow transit constipationBMC Gastroenterology, 2011
- Laxatives or methylnaltrexone for the management of constipation in palliative care patientsPublished by Wiley ,2010
- Pharmacologic Management of Chronic ConstipationGastroenterology Clinics of North America, 2010
- Feasibility of Internet-Based Health-Related Quality of Life Data Collection in a Large Patient CohortJournal of Medical Internet Research, 2010
- Burden of opioid-associated gastrointestinal side effects from clinical and economic perspectives: A systematic literature reviewJournal of Opioid Management, 2010
- The Prevalence, Severity, and Impact of Opioid-Induced Bowel Dysfunction: Results of a US and European Patient Survey (PROBE 1)Pain Medicine, 2009
- Gastrointestinal side effects in chronic opioid users: results from a population‐based surveyAlimentary Pharmacology & Therapeutics, 2008
- The Hawthorne Effect: a randomised, controlled trialBMC Medical Research Methodology, 2007
- Opioid-induced bowel dysfunction: prevalence, pathophysiology and burdenInternational Journal of Clinical Practice, 2007
- Opioid-Induced Emesis Among Hospitalized Nonsurgical Patients: Effect on Pain and Quality of LifeJournal of Pain and Symptom Management, 1999